Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential Effects of AIT on Nonspecific Allergic Immune Responses or Symptoms. | J Clin Med | 2023 | 37297972 | PubTator, text mining | PubMed |
| Combination of High-Resolution Structures for the B Cell Receptor and Co-Receptors Provides an Understanding of Their Interactions with Therapeutic Antibodies. | Cancers (Basel) | 2023 | 37296844 | PubTator, text mining | PubMed |
| Degranulation of Mast Cells as a Target for Drug Development. | Cells | 2023 | 37296626 | PubTator, text mining | PubMed |
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors. | Clin Cancer Res | 2023 | 37289194 | PubTator, text mining | PubMed |
| The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology. | Aging (Albany NY) | 2023 | 37285836 | PubTator, text mining | PubMed |
| Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses. | Front Endocrinol (Lausanne) | 2023 | 37274336 | PubTator, text mining | PubMed |
| Using human induced pluripotent stem cell-derived liver cells to investigate the mechanisms of liver fibrosis in vitro. | Biochem Soc Trans | 2023 | 37264940 | PubTator, text mining | PubMed |
| Production of recombinant human IgG1 Fc with beneficial N-glycosylation pattern for anti-inflammatory activity using genome-edited chickens. | Commun Biol | 2023 | 37264071 | PubTator, text mining | PubMed |
| An Fc-muted bispecific antibody targeting PD-L1 and 4-1BB induces antitumor immune activity in colorectal cancer without systemic toxicity. | Cell Mol Biol Lett | 2023 | 37259060 | PubTator, text mining | PubMed |
| Gut microbiota were altered with platelet count and red blood cell count in immune thrombocytopenia patients with different treatments. | Front Cell Infect Microbiol | 2023 | 37256109 | PubTator, text mining | PubMed |
| A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics. | Viruses | 2023 | 37243242 | PubTator, text mining | PubMed |
| Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation. | J Pers Med | 2023 | 37241015 | PubTator, text mining | PubMed |
| Deciphering the Genetic Code of Autoimmune Kidney Diseases. | Genes (Basel) | 2023 | 37239388 | PubTator, text mining | PubMed |
| Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus. | Front Immunol | 2023 | 37234154 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis-A Narrative Review. | Metabolites | 2023 | 37233716 | PubTator, text mining | PubMed |
| Fungal Aeroallergens-The Impact of Climate Change. | J Fungi (Basel) | 2023 | 37233255 | PubTator, text mining | PubMed |
| A publication-wide association study (PWAS), historical language models to prioritise novel therapeutic drug targets. | Sci Rep | 2023 | 37225853 | PubTator, text mining | PubMed |
| Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients. | Sci Rep | 2023 | 37221406 | PubTator, text mining | PubMed |
| A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD. | Sci Rep | 2023 | 37217548 | PubTator, text mining | PubMed |
| Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients. | Front Immunol | 2023 | 37215103 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=23